Federica Liotti

1.6k total citations
43 papers, 1.2k citations indexed

About

Federica Liotti is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Federica Liotti has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Immunology and 10 papers in Oncology. Recurrent topics in Federica Liotti's work include S100 Proteins and Annexins (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Glutathione Transferases and Polymorphisms (5 papers). Federica Liotti is often cited by papers focused on S100 Proteins and Annexins (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Glutathione Transferases and Polymorphisms (5 papers). Federica Liotti collaborates with scholars based in Italy, Russia and Japan. Federica Liotti's co-authors include Rosa Marina Melillo, Nella Prevete, Gianni Marone, Amato de Paulis, Carla Visciano, Renato Franco, Massimo Santoro, Francesca Collina, Elvira Avilla and Gaetano Calı̀ and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Federica Liotti

41 papers receiving 1.2k citations

Peers

Federica Liotti
Keyvan Mahboubi United States
Caishu Deng United States
Marie Sanson United States
Michael N. VanSaun United States
Urbain Weyemi United States
James X. Rong United States
Fei Fang China
Jae Mi Suh South Korea
Alykhan Motani United States
Keyvan Mahboubi United States
Federica Liotti
Citations per year, relative to Federica Liotti Federica Liotti (= 1×) peers Keyvan Mahboubi

Countries citing papers authored by Federica Liotti

Since Specialization
Citations

This map shows the geographic impact of Federica Liotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Liotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Liotti more than expected).

Fields of papers citing papers by Federica Liotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Liotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Liotti. The network helps show where Federica Liotti may publish in the future.

Co-authorship network of co-authors of Federica Liotti

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Liotti. A scholar is included among the top collaborators of Federica Liotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Liotti. Federica Liotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liotti, Federica, Maria Marotta, Chiara Simone, et al.. (2025). Formyl peptide receptor 1 signaling strength orchestrates the switch from pro-inflammatory to pro-resolving responses: The way to exert its anti-angiogenic and tumor suppressor functions. Biomedicine & Pharmacotherapy. 186. 117961–117961. 2 indexed citations
2.
Marotta, Maria, Nella Prevete, Chiara Simone, et al.. (2025). SHP2 is a multifunctional target in anaplastic thyroid carcinoma: Cell intrinsic and immune-dependent anti-tumor effects. Biomedicine & Pharmacotherapy. 190. 118384–118384. 1 indexed citations
3.
Marotta, Maria, Federica Liotti, Rosa Marina Melillo, & Nella Prevete. (2025). Tumor suppressor function of formyl peptide receptor 1 in gastrointestinal cancers: a focus on the underlying signaling. Frontiers in Cell and Developmental Biology. 13. 1733396–1733396.
4.
Martino, Marco De, Francesco Esposito, Federica Liotti, et al.. (2023). The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness. Cell Death Discovery. 9(1). 216–216. 5 indexed citations
5.
Ambrosio, Maria Rosaria, Domenico Liguoro, Fabrizio Schönauer, et al.. (2022). Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines. Cancers. 14(21). 5421–5421. 17 indexed citations
6.
Liotti, Federica, Maria Marotta, Daniela Sorriento, et al.. (2022). Probiotic Lactobacillus rhamnosus GG ( LGG ) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1. Molecular Oncology. 16(16). 2959–2980. 17 indexed citations
7.
Liotti, Federica, Maria Marotta, Rosa Marina Melillo, & Nella Prevete. (2022). The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression. Cancers. 14(14). 3333–3333. 18 indexed citations
8.
Collina, Francesca, Lucia La Sala, Federica Liotti, et al.. (2019). AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer. Cancers. 11(6). 785–785. 27 indexed citations
9.
Morra, Francesco, Francesco Merolla, Daniela Russo, et al.. (2019). CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC. Cancers. 11(10). 1582–1582. 14 indexed citations
10.
Prevete, Nella, Federica Liotti, Angela Amoresano, et al.. (2017). New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution. Pharmacological Research. 128. 80–87. 34 indexed citations
11.
Moretti, Sonia, Elisa Menicali, Nicole Nucci, et al.. (2016). Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1. Journal of Biological Chemistry. 292(5). 1785–1797. 20 indexed citations
12.
Prevete, Nella, Federica Liotti, Gianni Marone, Rosa Marina Melillo, & Amato de Paulis. (2015). Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth. Pharmacological Research. 102. 184–191. 92 indexed citations
13.
Visciano, Carla, Federica Liotti, Nella Prevete, et al.. (2015). Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway. Oncogene. 34(40). 5175–5186. 181 indexed citations
14.
Avilla, Elvira, Valentina Guarino, Carla Visciano, et al.. (2011). Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer. Cancer Research. 71(5). 1792–1804. 76 indexed citations
15.
Ruberto, Maria & Federica Liotti. (2011). [Obstructive sleep apnoea syndrome (OSAS) and mood disorders in a population of public transport drivers].. PubMed. 102(2). 201–7. 5 indexed citations
16.
Melillo, Rosa Marina, Vincenza Guarino, Elvira Avilla, et al.. (2010). Mast cells have a protumorigenic role in human thyroid cancer. Oncogene. 29(47). 6203–6215. 179 indexed citations
17.
Liotti, Federica, et al.. (1993). Putative role of antioxidant enzymes and glyoxalases in carcinogenesis.. PubMed. 80(1). 62–8; discussion 68. 1 indexed citations
18.
Liotti, Federica, et al.. (1989). Effects of dimethylsulfoxide on friend erythroleukemic cell proliferation and on the activity of enzymes involved in this process. International Journal of Cancer. 43(6). 1145–1148. 3 indexed citations
20.
Liotti, Federica, Giovanni Principato, & Vincenzo Nicola Talesa. (1985). Effect of ascorbic and dehydroascorbic acid on glyoxalase enzyme system.. PubMed. 55(2). 193–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026